Aptevo Therapeutics (APVO) Non Operating Income (2016 - 2022)
Historic Non Operating Income for Aptevo Therapeutics (APVO) over the last 8 years, with Q4 2022 value amounting to $21000.0.
- Aptevo Therapeutics' Non Operating Income rose 10082.13% to $21000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was -$4.0 million, marking a year-over-year increase of 4971.28%. This contributed to the annual value of -$4.0 million for FY2022, which is 4971.28% up from last year.
- According to the latest figures from Q4 2022, Aptevo Therapeutics' Non Operating Income is $21000.0, which was up 10082.13% from -$25000.0 recorded in Q3 2022.
- In the past 5 years, Aptevo Therapeutics' Non Operating Income registered a high of $21000.0 during Q4 2022, and its lowest value of -$2.6 million during Q4 2021.
- For the 5-year period, Aptevo Therapeutics' Non Operating Income averaged around -$1.0 million, with its median value being -$700000.0 (2018).
- As far as peak fluctuations go, Aptevo Therapeutics' Non Operating Income surged by 10091.74% in 2020, and later tumbled by 5865000.0% in 2021.
- Aptevo Therapeutics' Non Operating Income (Quarter) stood at -$700000.0 in 2018, then soared by 37.71% to -$436000.0 in 2019, then grew by 19.27% to -$352000.0 in 2020, then tumbled by 626.42% to -$2.6 million in 2021, then surged by 100.82% to $21000.0 in 2022.
- Its last three reported values are $21000.0 in Q4 2022, -$25000.0 for Q3 2022, and -$1.8 million during Q2 2022.